Industry ties to patient advocacy board members, execs raise concerns Business, Therapeutics Most leading U.S. patient advocacy organizations have board members or senior leaders with ties that raise questions about industry influence over their policies, according to a research letter published Monday in JAMA Internal Medicine. Read more August 22, 2023/by BioSpace https://www.pharmalive.com/wp-content/uploads/2023/08/BioSpaceboard.jpg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2023-08-22 08:00:172023-08-22 11:59:23Industry ties to patient advocacy board members, execs raise concerns
